Key result
SGLT2 inhibitors and ARNIs represent recent progress in heart failure management.
Design
Review
A review discussing recent progress in heart failure management, including SGLT2 inhibitors and ARNIs, in the context of atrial fibrillation.
Recent years have witnessed progress in the management of heart failure through the development of SGLT2 inhibitors and angiotensin receptor neprilysin inhibitors [...].
No takes yet. Share an insight, caveat, or question.
Anter et al. (2009) studied this question. SGLT2 inhibitors and angiotensin receptor neprilysin inhibitors represent recent progress in the management of heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: